SPRINGDALE, Ark., Dec. 17, 2020 /PRNewswire/ Effective December 8, 2020,
NOWDiagnostics, Inc. has received Conformité Européene (CE) mark approval for its ADEXUSDx® COVID-19 antibody fingerstick Test for use across 28 countries in the European Union (EU). The test first received CE mark approval for use in moderate/complex laboratory settings on July 28, 2020. The application for fingerstick use of the test was submitted November 2020 following completion of a Clinical Laboratory Improvement Amendments of 1988 (CLIA) Waiver trial in the United States (U.S.).
C19 Development, LLC, a wholly owned subsidiary of NOWDiagnostics, will begin offering the ADEXUSDx® COVID-19 Test for fingerstick use in a variety of health care settings in the EU from clinics to hospital emergency rooms, while launching clinical trials of the test for use over the counter.
Clarksville Now
CLARKSVILLE, Tenn. (CLARKSVILLENOW) – Austin Peay State University officials expect to administer up to 25,000 COVID-19 vaccinations in the coming months to university students, employees and their families.
Additionally, Austin Peay plans to open a new clinical laboratory Jan. 4 on campus that will help university healthcare workers deliver quicker, more accurate COVID-19 testing and results, according to a release sent by the university..
The news comes as the COVID-19 pandemic has intensified across the country and in Tennessee, where the state is averaging more than 8,000 infections and 70 deaths per day.
Austin Peay will be one of the vaccination pods in Montgomery County.
Austin Peay State University set up a COVID-19 testing site last summer. (APSU)
Additionally, Austin Peay State University plans to open a new clinical laboratory January 4th, 2021 on campus that will help university healthcare workers deliver quicker, more accurate COVID-19 Coronavirus testing and results.
The news comes as the COVID-19 Coronavirus pandemic has intensified across the country and in Tennessee, where the state is averaging more than 8,000 infections and 70 deaths per day.
Vaccinating up to 25,000 people
Austin Peay State University will be one of the vaccination pods in Montgomery County, said Dr. Heather Phillips, director of the university’s new clinical laboratory.
Share this article
Share this article
SAN CARLOS, Calif., Dec. 18, 2020 /PRNewswire/ Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA (cfDNA) testing, is pleased that the United States Patent Office granted Natera a significant win when it denied a patentability challenge from a multi-national sequencing company against Natera s U.S. Patent No. 8,682,592 ( 592 Patent) upholding all claims. Natera s 592 Patent claims early and significant innovations directed to generating genetic data from limited quantities of DNA, including cfDNA. Natera has shown the techniques to be useful in a variety of contexts such as non-invasive prenatal testing, ctDNA molecular residual disease testing in oncology, and donor-derived cfDNA assessment in organ transplant recipients.
Penn State to begin spring semester remotely, delay in-person classes psu.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from psu.edu Daily Mail and Mail on Sunday newspapers.